Import Bc3316-02 — Buy in wholesale FOB from Supplier in India

The BC3316-02 is a clinical diagnostic kit configured for laboratory-based immunoassay testing, utilizing a mixed reagent composition of antibodies, substrates, and buffers. It is supplied in a 100-test or 96-well plate format, the latter representing the established industry standard for ELISA workflows. The unit cost is 26,670 INR, reflecting the larger pack size compared to related SKUs. Manufactured in Kerala, India, the kit targets pathology laboratories and clinical research facilities requiring higher-throughput diagnostic capacity. The HS code 3822.00 classification covers in-vitro diagnostic reagents and kits for customs purposes.

The 96-well microplate format enables simultaneous processing of multiple samples and controls, reducing per-test labor cost and improving inter-assay consistency. Antibodies are typically monoclonal or polyclonal, selected for specificity to the target analyte, while substrates produce a measurable signal upon enzymatic reaction. Buffer systems maintain optimal pH and ionic strength for binding kinetics. The reagent composition requires standard cold storage to preserve antibody affinity and enzymatic activity. Typical shelf life for such formulations ranges 12-24 months, though buyers must verify lot-specific stability data.

This configuration appeals to reference laboratories, hospital chains with centralized labs, and diagnostic distributors serving multiple collection points. The bulk pack sizing supports procurement strategies for facilities processing 80-100 samples per day. Importers should confirm regulatory status in destination markets, as 96-well ELISA kits may require CE-IVD marking, FDA clearance, or local registration. The supplier's location in Kollam, Kerala, positions it within India's southern pharmaceutical and biotechnology corridor, though buyers must independently verify production capabilities and compliance standards.

Origin Diagnostics & Research is headquartered in Clappana, Karunagappally, within the Kollam district of Kerala, India. The supplier holds a harbor trust tier, representing entry-level platform verification. Notably, the response rate is 0.00% with zero recorded average response hours, indicating no confirmed engagement through platform messaging. Prospective buyers should not rely on platform communication alone; direct outreach via the Kerala address or established business contacts is essential to gauge actual responsiveness and account management quality.

The company's listed offering centers on diagnostic reagent kits for clinical and research applications, with the BC3316-02 representing its higher-capacity 96-well format product. No information is provided on manufacturing facility size, GMP compliance, research and development capacity, or clientele. Specific accreditations such as ISO 13485 or national drug controller approvals are absent from the profile. Importers must conduct due diligence by requesting facility audit reports, quality manual excerpts, and regulatory dossiers to assess suitability for their supply chain.